Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of MiR-503 cluster sponge in preparation of medicine for treating type 2 diabetes

A type 2 diabetes, mir-503 technology, applied in the field of biomedicine, can solve the problems of lack of treatment methods and high treatment costs, and achieve the effects of peripheral tissue insulin sensitivity recovery, function improvement, and glucose tolerance improvement.

Active Publication Date: 2022-05-06
NANJING MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The miR-503 cluster sponge seals the expression of miR-503 cluster in pancreatic islet β cells, and further applies it to the preparation of drugs for the treatment of type 2 diabetes, so as to solve the lack of current treatment methods and high treatment costs for type 2 diabetes. question

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of MiR-503 cluster sponge in preparation of medicine for treating type 2 diabetes
  • Application of MiR-503 cluster sponge in preparation of medicine for treating type 2 diabetes
  • Application of MiR-503 cluster sponge in preparation of medicine for treating type 2 diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1 Expression of miR-503 in chronic inflammation model mouse tissues.

[0029] Experimental animals: Male C57BL / 6J mice were purchased from the Institute of Model Animals, Nanjing University. All animal experiments were approved by the Experimental Animal Management Committee of Nanjing Medical University, and all experimental animals were kept in a barrier facility in the Experimental Animal Center of Nanjing Medical University in a clean environment with a temperature of (21±2)°C and a humidity of (35±2) )%, 12h: 12h day and night without lighting, free to eat and drink, the drinking water is the sterile water prepared by the experimental animal center.

[0030] Experimental results: if figure 1 As shown, in order to screen miRNAs that change and have significant effects in cells under chronic inflammatory conditions, we treated INS-1 cells with 10 ng / ml IL-1β, and collected four groups of samples at different time points to prepare miRNA chip, the results ar...

Embodiment 2

[0031] Example 2 The role of miR-503 cluster in vivo during the development of type 2 diabetes.

[0032] Experimental animals: In order to explore the role of miR-503 cluster in the development of diabetes, we used miR-503 cluster knockout (KO) mice.

[0033] experimental method:

[0034] 1) Construct miR-503 cluster whole-body knockout mice, 10 WT and KO mice, fed normal diet (NCD) and high-fat diet (HFD), and monitored fasting and postprandial blood glucose levels once a month. The mice were fasted for 12-16 hours in advance during the fasting blood glucose test; the postprandial blood glucose test was fasted and then fed, and the blood glucose level was detected 2 hours after eating.

[0035] 2) When differences in fasting or postprandial blood glucose levels were detected, glucose tolerance (GTT), in vitro islet perfusion and insulin tolerance (ITT) experiments were performed on the mice. The GTT detection method is to measure the blood glucose value at 0, 5, 15, 30, 60,...

Embodiment 3

[0038] Example 3 Blocking the effect of β-cell-derived miR-503 clusters can reverse the diabetic phenotype in aged mice.

[0039] Experimental drugs: MIP1-mmu-miR-503-424-Sponge, negative control MIP1-NC-GFP, all commissioned to Weizhen Biotechnology Co., Ltd., all using type 8 adeno-associated virus vector pAAV-MCS to construct recombinant plasmids; auxiliary plasmids Select pAAV-RC; select pHelper for adenovirus plasmid; select AAV-293 cells for competent cells; resistance: Amp, insulin promoter for the promoter, specifically use the mouse insulin 1 promoter (mouse insulin1 promoter, MIP1).

[0040] experimental method:

[0041] 1) Select 13 60-week-old mice, and use 10-week-old mice as controls to detect their body weight, fasting blood glucose level, glucose tolerance and insulin tolerance, and then divide the mice into two batches and inject the recombinant virus. The 6 rats in the batch were divided into two groups and injected with the control virus and the miR-503 spo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of miR-503 cluster sponge in preparation of a medicine for treating type 2 diabetes mellitus, the miR-503 cluster sponge inhibits miR-503 and miR-424 (called miR-322 in mice) in a targeted manner, the miR-503 cluster sponge closes the expression of miR-503 and miR-424 / miR-322 in beta cells, and the miR-503 cluster sponge is further applied to preparation of the medicine for treating the type 2 diabetes mellitus. The problems that current treatment methods for type 2 diabetes mellitus are deficient and the treatment cost is high are solved.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to the application of a miR-503 cluster sponge in the preparation of drugs for treating type 2 diabetes. Background technique [0002] Diabetes mellitus (DM) is a systemic metabolic disorder syndrome characterized by chronic hyperglycemia caused by relative or absolute insulin deficiency. According to the latest report of the International Diabetes Federation, about 463 million adults aged 20-79 suffer from diabetes in 2019; it is estimated that by 2030, the number of diabetic patients will reach 578.4 million, accounting for about 8% of the world's total population, which not only affects the physical and mental health of patients It also creates a significant burden on social medical expenditure. Diabetes can be divided into type 1, type 2, gestational and other types of diabetes, among which type 2 diabetes (T2DM) accounts for more than 95% of patients. Therefor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7105A61P3/10C12N15/113
CPCA61K31/7105A61P3/10C12N15/113C12N2310/113C12N2310/14C12N2320/32C12N2800/107
Inventor 朱云霞韩晓刘可容周云财张艳唐伟李雅婷常晓嫒
Owner NANJING MEDICAL UNIV